84 related articles for article (PubMed ID: 9272979)
21. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
Brewster AM; Christo DK; Lai H; Helzlsouer K
Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
[TBL] [Abstract][Full Text] [Related]
22. Risk of recurrence after ductal carcinoma in situ of the breast.
Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
[TBL] [Abstract][Full Text] [Related]
23. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
24. MRI screening in a clinic population with a family history of breast cancer.
Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
[TBL] [Abstract][Full Text] [Related]
25. Conjugated linoleic acid and the risk of breast cancer.
Chajès V; Lavillonnière F; Ferrari P; Jourdan ML; Pinault M; Maillard V; Sébédio JL; Bougnoux P
IARC Sci Publ; 2002; 156():203-4. PubMed ID: 12484165
[No Abstract] [Full Text] [Related]
26. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
[TBL] [Abstract][Full Text] [Related]
27. Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany.
Wang-Gohrke S; Chang-Claude J
Breast Cancer Res Treat; 2004 Dec; 88(3):231-7. PubMed ID: 15609125
[TBL] [Abstract][Full Text] [Related]
28. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004.
Ahn SH; Yoo KY;
Breast Cancer Res Treat; 2006 Sep; 99(2):209-14. PubMed ID: 16862450
[TBL] [Abstract][Full Text] [Related]
29. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
Kolb GF
Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
[TBL] [Abstract][Full Text] [Related]
30. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
Wärnberg F; Bergh J; Zack M; Holmberg L
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer.
Sauter ER; Qin W; Schlatter L; Hewett JE; Flynn JT
BMC Cancer; 2006 Oct; 6():248. PubMed ID: 17049084
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk: the role of the nurse practitioner.
Kelly PT
Nurse Pract Forum; 1993 Jun; 4(2):91-5. PubMed ID: 8513269
[TBL] [Abstract][Full Text] [Related]
34. One in nine: risks and prevention strategies for breast cancer.
Appling SE
Medsurg Nurs; 1996 Feb; 5(1):62-4. PubMed ID: 8696413
[No Abstract] [Full Text] [Related]
35. [High risk groups of breast cancer].
Tominaga S
Gan No Rinsho; 1989 May; Spec No():212-9. PubMed ID: 2601012
[No Abstract] [Full Text] [Related]
36. Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling.
Brekelmans CT; Bartels CC; Crepin E; van Geel AN; Meijers-Heijboer H; Seynaeve C; Tilanus-Linthorst MM; Verhoog LC; Wagner A; Klijn JG
Dis Markers; 1999 Oct; 15(1-3):34-6. PubMed ID: 10595248
[No Abstract] [Full Text] [Related]
37. Breast cancer in Wisconsin: the potential for primary prevention.
Lantz PM; Remington PL
Wis Med J; 1991 Sep; 90(9):538-40. PubMed ID: 1949875
[No Abstract] [Full Text] [Related]
38. Retinoids and breast cancer.
Band PR; Coldman AJ; Deschamps M
Prog Clin Biol Res; 1990; 354A():361-77. PubMed ID: 2247499
[No Abstract] [Full Text] [Related]
39. [Carcinoma of the breast. Epidemiologic studies].
Merletti F; Terracini B
Minerva Chir; 1988 Sep; 43(18 Suppl):1-4. PubMed ID: 3226588
[No Abstract] [Full Text] [Related]
40. Breast cancer prevention using calcium and vitamin D: a bright future?
Speers C; Brown P
J Natl Cancer Inst; 2008 Nov; 100(22):1562-4. PubMed ID: 19001596
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
